Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
ALGS Aligos Therapeutics
- 10.510
- +0.100+0.96%
Close Mar 11 16:00 ET
- 10.510
- 0.0000.00%
Post 16:05 ET
64.26MMarket Cap-0.50P/E (TTM)
10.800High9.670Low153.44KVolume10.300Open10.410Pre Close1.58MTurnover3.52%Turnover RatioLossP/E (Static)6.11MShares46.80052wk High-2.22P/B45.83MFloat Cap6.76052wk Low--Dividend TTM4.36MShs Float937.748Historical High--Div YieldTTM10.85%Amplitude6.760Historical Low10.271Avg Price1Lot Size
Aligos Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -74.60%3.95M | -76.54%629K | -60.82%1.27M | -84.59%1.06M | -63.79%986K | 11.66%15.53M | -24.20%2.68M | -21.12%3.24M | 86.46%6.89M | 5.91%2.72M |
| Operating revenue | -74.60%3.95M | -76.54%629K | -60.82%1.27M | -84.59%1.06M | -63.79%986K | 11.66%15.53M | -24.20%2.68M | -21.12%3.24M | 86.46%6.89M | 5.91%2.72M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -10.18%93.1M | -26.10%21.19M | -4.08%21.4M | 5.56%27.48M | -13.55%23.03M | -7.02%103.66M | 9.38%28.68M | -3.23%22.31M | 8.06%26.03M | -30.13%26.64M |
| Selling and administrative expenses | -25.43%22.83M | -19.62%5.16M | -28.20%4.63M | -31.04%6.38M | -21.63%6.67M | 15.93%30.62M | -9.80%6.42M | 22.42%6.44M | 22.04%9.25M | 31.84%8.51M |
| -General and administrative expense | -25.43%22.83M | -19.62%5.16M | -28.20%4.63M | -31.04%6.38M | -21.63%6.67M | 15.93%30.62M | -9.80%6.42M | 22.42%6.44M | 22.04%9.25M | 31.84%8.51M |
| Research and development costs | -3.79%70.27M | -27.97%16.03M | 5.72%16.77M | 25.73%21.1M | -9.75%16.37M | -14.15%73.04M | 16.53%22.26M | -10.81%15.87M | 1.64%16.78M | -42.75%18.14M |
| Operating profit | -1.17%-89.15M | 20.90%-20.56M | -5.56%-20.13M | -38.00%-26.41M | 7.83%-22.05M | 9.69%-88.13M | -14.62%-26M | -0.65%-19.07M | 6.14%-19.14M | 32.73%-23.92M |
| Net non-operating interest income expense | 254.47%4.41M | 46.21%-788K | -54.53%457K | -66.60%319K | -22.46%580K | -24.21%1.24M | -267.24%-1.47M | 115.67%1.01M | 350.47%955K | 769.77%748K |
| Non-operating interest income | ---- | ---- | -54.53%457K | -66.60%319K | -22.46%580K | -24.21%1.24M | -267.24%-1.47M | 115.67%1.01M | 350.47%955K | 769.77%748K |
| Total other finance cost | ---4.41M | --788K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expense) | -46.13M | -60.77M | 837.04%506K | 20,521.71%31.35M | -5,364.96%-13.37M | 129.67%54K | -50.00%152K | 379.12%254K | ||
| Gain on sale of security | ---46.13M | ---60.77M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | 837.04%506K | 20,521.71%31.35M | -5,364.96%-13.37M | ---- | ---- | 129.67%54K | -50.00%152K | 379.12%254K |
| Income before tax | -50.64%-130.88M | -194.12%-82.12M | -6.42%-19.17M | 129.11%5.25M | -52.03%-34.84M | 9.44%-86.88M | -27.87%-27.92M | 3.49%-18.01M | 9.27%-18.03M | 35.56%-22.92M |
| Income tax | -58.36%331K | 190.00%27K | 213.79%91K | -75.03%189K | -38.46%24K | 650.00%795K | -161.22%-30K | 167.44%29K | 1,510.64%757K | -26.42%39K |
| Net income | -49.65%-131.21M | -194.53%-82.15M | -6.75%-19.26M | 126.93%5.06M | -51.88%-34.86M | 8.71%-87.68M | -27.44%-27.89M | 3.11%-18.04M | 5.69%-18.79M | 35.55%-22.96M |
| Net income continuous Operations | -49.65%-131.21M | -194.53%-82.15M | -6.75%-19.26M | 126.93%5.06M | -51.88%-34.86M | 8.71%-87.68M | -27.44%-27.89M | 3.11%-18.04M | 5.69%-18.79M | 35.55%-22.96M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -49.65%-131.21M | -194.53%-82.15M | -6.75%-19.26M | 126.93%5.06M | -51.88%-34.86M | 8.71%-87.68M | -27.44%-27.89M | 3.11%-18.04M | 5.69%-18.79M | 35.55%-22.96M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -49.65%-131.21M | -194.53%-82.15M | -6.75%-19.26M | 126.93%5.06M | -51.88%-34.86M | 8.71%-87.68M | -27.44%-27.89M | 3.11%-18.04M | 5.69%-18.79M | 35.55%-22.96M |
| Basic earnings per share | 38.41%-20.94 | -40.87%-13.08 | 70.40%-3.07 | 106.98%0.75 | 58.49%-5.5 | 39.56%-34 | 27.17%-9.2853 | 5.73%-10.37 | 8.51%-10.75 | 36.90%-13.25 |
| Diluted earnings per share | 38.41%-20.94 | -40.87%-13.08 | 70.40%-3.07 | 106.98%0.75 | 58.49%-5.5 | 39.56%-34 | 27.17%-9.2853 | 5.73%-10.37 | 8.51%-10.75 | 36.90%-13.25 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |